Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative ...

Organon will discontinue its OG-6219 clinical-development program, after the investigational candidate failed to meet its primary efficacy endpoint in treating endometriosis-related pain.

Learn how integrin proteins are used as quality tools for targeted drug development.

Chart Industries Inc. (NYSE:GTLS) is one of the 10 most undervalued industrial stocks to buy according to analysts.

To produce a successful final drug formulation, Pii started using machine learning in the early stages of drug development, such as optimizing a drug’s solubility.

Massive Bio named by CB Insights for AI-driven clinical trial matching and patient recruitment in oncology.

Flowserve Corporation and Chart Industries, Inc. merge for $300M synergies, sparking investor skepticism on growth and strategy. Click for my take on FLS and GTLS.

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in ...

Proteins represent 95% of drug targets designed to combat disease, according to Yvonne Tan, PhD, from Nuclera.